3Wells RG. Cellular sources of extracellular matrix in hepatic fibrosis [J]. Clin Liver Dis, 2008,12(4) : 759-768.
4Phanish MK, Winn SK, Dockrell MK. Conective tissuegrowth factor (CTGF, CCN2) a marker, mediator and ther- apeutic target for renal fibrosis [ J ]. Nephron Exp Nephrol, 2010,114(3) : e83-92.
5Alisi A, Feldstein AE, Villani A, et al. Pediatric nonalco- holic fatty liver disease: a muhidisciplinary approach : J ]. Nat Rev Gastroenterol Hepatol, 2012,9(3) : 152-61.
6Lin YL, Lin CY, Chi CW, et al. Study on antifibrotic effects curcumin in rat hepatic stellate cells [ J ]. Phytother Res, 2009,23(7) :927-932.
7Hayashi H, Sakai T. Biological significance of local. TGF-β activation in liver diseases [ J]. Front Physiol, 2012,3:12.
8Leask A, Abraham DJ. The role of connective tissue growth factor, a muhifunctional matricellular protein, in fibroblast biology [J]. Biochem Cell Bio, 2003,81:355-363.
9Adams LA.Biomarkers of liver fibrosis[J].J Gastroen Hepatol,2011,26 (5):802-809.
10Nan XP,Zhang Y,Yu HT,et al.Circulating CD4+CD25+high regulatory T cells and expression of PD-1 and BTLA on CD4+Tcells in patients with chronic hepatitis B virus infection[J].Viral Immunol,2010,23 (1):63-70.
